TMDX
TransMedics Group, Inc. [TMDX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TMDX Stock Summary
Top TMDX Correlated Resources
TMDX
Top 10 Correlated ETFs
TMDX
Top 10 Correlated Stocks
TMDX
In the News
TMDX Financial details
Company Profile
- Volume Average 696.83K
- Market Capitalization 3B
- Employee 584
- CEO Dr. Waleed H. Hassanein M.D.
- Headquarters Andover,MA,US
- IPO Date 2019-05-02
-
Website
https://www.transmedics.com 
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
